EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The L108I polymorphism in mouse prion protein drives spontaneous disease and enhances transmission of atypical and classical prion strains

Hasier Eraña, Enric Vidal, Natalia Fernández-Borges, Jorge M Charco, Carlos M Díaz-Domínguez, Cristina Sampedro-Torres-Quevedo, Josu Galarza-Ahumada, Eva Fernández-Muñoz, Maitena San-Juan-Ansoleaga, Miguel Ángel Pérez-Castro, Nuno Gonçalves-Anjo, Patricia Piñeiro und 9 weitere

Brain Pathology · 2026

DOI: 10.1111/bpa.70083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Pathology, 2026. Verfasst von Hasier Eraña und 20 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cooperative Research in Biosciences (CIC BioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain. Hauptthemen laut MEDLINE: Prion Diseases, Prions, Prion Proteins. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación, Interreg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prion diseases are fatal neurodegenerative disorders that can be idiopathic, associated with genetic mutations, or acquired by infection with misfolded prion protein. We developed two complementary transgenic mouse models to investigate how the L108I substitution in mouse prion protein (PrP) influences spontaneous prion formation and transmission characteristics. The transgenic mouse model overexpressing the variant at approximately three times wild‐type (WT) PrP levels (TgMo(L108I)3x) consistently developed a spontaneous neurodegenerative disorder between 219 and 536 days of age with 100% penetrance. This spontaneous disease exhibited biochemical and neuropathological characteristics of atypical prion disorders, featuring a distinctive 7–10 kDa protease‐resistant PrP fragment and pathology comparable to small ruminants' atypical scrapie and certain forms of Gerstmann–Sträussler–Scheinker syndrome (GSS). In contrast, the knock‐in model expressing the same variant at physiological levels (TgMo(L108I)1x) showed no spontaneous disease beyond 600 days, demonstrating that both the specific amino acid substitution and elevated expression levels are necessary for spontaneous prion formation. The spontaneously generated prions transmitted efficiently to models expressing the I108 variant and to Tga20 mice overexpressing WT PrP but encountered a robust transmission barrier toward WT mice, indicating strain‐specific replication requirements. The TgMo(L108I)3x model demonstrated exceptional versatility as a universal acceptor for heterogeneous prion isolates, demonstrating superior efficiency in propagating atypical variants like GSS A117V (57 ± 0.6 days) and rapid propagation of classical scrapie‐derived mouse prion strains, including Rocky Mountains Laboratory mouse prion strain (RML) (85 ± 3.8 days) and 22L (95 ± 1 days). Comparative analysis revealed that the L108I substitution differentially impacts strain propagation, with greater acceleration of RML (~33% shorter incubation) than 22L (~0.5% shorter) compared to WT mice. These complementary systems offer powerful experimental platforms for investigating the molecular determinants of spontaneous prion formation, strain selection and transmission barriers, providing insights into idiopathic prion pathogenesis and developing therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prion DiseasesPrionsPrion ProteinsAnimalsMice, TransgenicMiceBrainDisease Models, AnimalPolymorphism, GeneticScrapieGerstmann-Straussler-Scheinker Disease

Stichwörter der Autor:innen

CRISPR‐CasL108I polymorphismatypical prionsprion diseasesprion strainsprion transmissionspontaneous neurodegenerationtransgenic mice

Substanzen

PrionsPrion Proteins

Autor:innen und Institutionen

  • Center for Cooperative Research in Biosciences (CIC BioGUNE), Basque Research and Technology Alliance (BRTA), Derio, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades infecciosas (CIBERINFEC), Carlos III National Health Institute, Madrid, Spain.
  • ATLAS Molecular Pharma S. L., Derio, Spain.
  • IRTA, Programa de Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, Catalonia, Spain.
  • Unitat mixta d'Investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), Bellaterra, Catalonia, Spain.
  • Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.

ORCID-Profile: Joaquín Castilla

Förderung

  • Agencia Estatal de Investigación
  • Ministerio de Ciencia e Innovación
  • Interreg
  • Instituto de Salud Carlos III
  • Fundación Tatiana Pérez de Guzmán el Bueno
  • Creutzfeldt-Jakob Disease Foundation-2022

Zitieren

APA

Eraña, H., Vidal, E., Fernández-Borges, N., Charco, J. M., Díaz-Domínguez, C. M., Sampedro-Torres-Quevedo, C., Galarza-Ahumada, J., Fernández-Muñoz, E., San-Juan-Ansoleaga, M., Pérez-Castro, M. Á., Gonçalves-Anjo, N., Piñeiro, P., Giler, S., González-Martín, N., Lorenzo, N. L., Manero-Azua, A., Perez de Nanclares, G., Geijo, M., Sánchez-Martín, M. A., …, & Castilla, J. (2026). The L108I polymorphism in mouse prion protein drives spontaneous disease and enhances transmission of atypical and classical prion strains. Brain Pathology. https://doi.org/10.1111/bpa.70083

Vancouver

Eraña H, Vidal E, Fernández-Borges N, Charco JM, Díaz-Domínguez CM, Sampedro-Torres-Quevedo C, et al. The L108I polymorphism in mouse prion protein drives spontaneous disease and enhances transmission of atypical and classical prion strains. Brain Pathology. 2026. doi:10.1111/bpa.70083

BibTeX
@article{Eraa2026,
  author = {Eraña, Hasier and Vidal, Enric and Fernández-Borges, Natalia and Charco, Jorge M and Díaz-Domínguez, Carlos M and Sampedro-Torres-Quevedo, Cristina and Galarza-Ahumada, Josu and Fernández-Muñoz, Eva and San-Juan-Ansoleaga, Maitena and Pérez-Castro, Miguel Ángel and Gonçalves-Anjo, Nuno and Piñeiro, Patricia and Giler, Samanta and González-Martín, Nora and Lorenzo, Nuria L and Manero-Azua, Africa and Perez de Nanclares, Guiomar and Geijo, Mariví and Sánchez-Martín, Manuel A and Requena, Jesús R and Castilla, Joaquín},
  title = {The L108I polymorphism in mouse prion protein drives spontaneous disease and enhances transmission of atypical and classical prion strains},
  journal = {Brain Pathology},
  year = {2026},
  doi = {10.1111/bpa.70083}
}
Kostenlos starten →